InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,592.18
(
-0.60%
)
US TECH 100
18,638.40
(
-2.27%
)
Dow Jones
41,091.42
(
-0.39%
)
Brent Oil
77.73
(
0.39%
)
Bitcoin
59,127.99
(
0.17%
)
Post# of 346238
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Robert C Jonson

Send PM Follow Ignore
Followers 29
Posts 2137
Boards Moderated 0
Alias Born 10/28/2007

Robert C Jonson

Re: RRdog post# 107522

Saturday, 01/12/2013 12:20:39 PM

Saturday, January 12, 2013 12:20:39 PM

Post# of 346238
That is ---- the 3mg unaffected arm of the 2nd line NSCLC trial was the best trial result in the history of that disease

And that is with patients who were sicker than in all but one other trial, isn't that so?

Good point, RRdog.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

FEATURED Element79 Gold Corp Appoints Warren Levy to Board of Directors • Aug 28, 2024 9:51 AM

Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM

ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM

North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM

PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM

Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!